Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biohaven Pharmaceutical Holding Co (DE:2VN)
FRANKFURT:2VN
RESEARCH TOOLSreports
Biohaven Pharmaceutical Holding Co (2VN) Financial Statements
0 Followers
Biohaven Pharmaceutical Holding Co Financial Overview
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 215.08M | $ 318.85M | $ 190.01M | $ 135.74M | $ 92.93M |
| Gross Profit | $ 179.34M | $ 292.51M | $ 154.06M | $ 110.23M | $ 75.59M |
| EBIT | $ -398.56M | $ -50.15M | $ -158.27M | $ -141.85M | $ -176.43M |
| EBITDA | $ -393.18M | $ -45.74M | $ -150.33M | $ -136.14M | $ -170.21M |
| Net Income Common Stockholders | $ -441.39M | $ -209.07M | $ -199.18M | $ -171.82M | $ -210.62M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 553.49M | $ 602.48M | $ 364.59M | $ 520.44M | $ 366.11M |
| Total Assets | $ 1.39B | $ 1.37B | $ 1.08B | $ 1.13B | $ 845.89M |
| Total Debt | $ 764.98M | $ 634.11M | $ 626.72M | $ 619.27M | $ 274.14M |
| Net Debt | $ 211.50M | $ 31.63M | $ 262.13M | $ 98.83M | $ -91.97M |
| Total Liabilities | $ 2.19B | $ 1.84B | $ 1.76B | $ 1.66B | $ 1.24B |
| Stockholders Equity | $ -800.93M | $ -462.29M | $ -739.38M | $ -587.98M | $ -453.88M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -190.92M | $ -24.16M | $ -193.44M | $ -205.00M | $ -227.51M |
| Operating Cash Flow | $ -134.04M | $ -23.64M | $ -193.39M | $ -204.99M | $ -227.04M |
| Investing Cash Flow | $ 56.97M | $ -244.27M | $ -174.31M | $ 40.23M | $ 40.87M |
| Financing Cash Flow | $ 141.93M | $ 267.99M | $ 37.06M | $ 361.60M | $ 25.17M |
Biohaven Pharmaceutical Holding Co Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.